.png)
Neurorehabilitation Devices Market by Product and Application - Global Industry Analysis and Forecast to 2027
Published On : August 2017 Pages : 102 Category: Medical Devices Report Code : HC06133
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
The global neurorehabilitation devices market is expected to be around $4 billion by 2027. The market is primarily driven by factors such as increasing incidence of neurological diseases such as stroke, Parkinson’s disease and Alzheimer disease. The increasing incidence of stroke can also be attributed to the rising demand for neurorehabilitation devices. As per the data revealed by the Center for Disease Control and Prevention (CDC) in May 2022, over 795,000 cases of stroke are reported every year in the U.S., of which around 610,000 cases are of first stroke. With continuous technological advancements, novel techniques for treating neurological disorders have been introduced in the market, which are further contributing to the growth of neurorehabilitation devices market around the world. However, factors such as dearth of skilled technicians to handle sophisticated neurorehabilitation devices and high costs of neurorehabilitation devices can restrain the growth of global neurorehabilitation devices market during the forecast period.
Product Outlook and Trend Analysis
Neurorobotics segment held the largest share of the global neurorehabilitation devices market in 2017 owing to the recent advancements in this field in the form of prosthetics and exoskeletons along with the ability to combine neuroscience and robotics to deliver effective neurological rehabilitation. Exoskeletons assist patients suffering from neurological disorders to enhance their motor performance by allowing them to achieve selective control over movement of joints. The level of assistance provided by exoskeletons can be adjusted according to the patient’s needs. Such advanced rehabilitation devices are revolutionizing the field of neurorehabilitation in a significant manner.
Application Outlook and Trend Analysis
Stroke is one of the major neurological disorders leading to physical disabilities among the patients. Typically there are two types of strokes viz. ischaemic strokes and hemorrhagic strokes. Ischaemic strokes occur due to cutting or blockage of blood supply to the brain. Hemorrhagic strokes occur when a blood vessel ruptures within the brain or on its surface. Majority of the instances of strokes are ischaemic in nature. According to the stroke statistics published in January 2017 by the Stroke Association, UK, nearly 152,000 incidences of stroke are reported every year in the UK that is one incidence every 3 minutes and 27 seconds. Almost 17 million incidences of first-time occurrence of stroke are reported every year worldwide. With such significant incidence, the stroke segment is expected to witness favorable growth during the forecast period.
Regional Outlook and Trend Analysis
North America held the largest share of the global neurorehabilitation devices market in 2017 owing to factors such as increasing geriatric population, increasing incidence of neurological disorders, especially stroke, and availability of advanced healthcare infrastructure in the region. Asia-Pacific neurorehabilitation devices market is expected to register lucrative growth during the forecast period owing to high incidence of neurological disorders resulting from road accidents and presence of highly unmet medical needs of the population in emerging countries such as India and China.
Competitive Analysis
Product development is one of the major strategies adopted by the leading players operating in the global neurorehabilitation devices market in order to design and develop advanced products intended for effective rehabilitation and in turn secure a larger share of the market. For instance, in February 2022, Bioness, Inc., one of the leading providers of rehabilitation therapies, obtained FDA clearance for its L300 Go system, the first functional electric stimulation system which offers 3D motion detection of gait events along with muscle activation using data from an accelerometer and a 3-axis gyroscope. Some of the key players operating in the global neurorehabilitation devices market are, Bioness Inc., Hocoma AG, Tyromotion GmbH, St. Jude Medical, Inc. (Acquired by Abbott Laboratories Inc.), Medtronic plc, AlterG, Inc., Ekso Bionics Holdings, Inc., Biometrics Ltd, , Kinova Robotics, Saebo, Inc., Kinestica and Bionik Laboratories Corp.
Market Opportunities
The future growth opportunities for global neurorehabilitation devices market lie in the development and commercialization of technologically advanced rehabilitation solutions specifically targeted towards treating distinct neurological disorders in a shorter time span with improved results. Increased investment in research and development activities by key market players will facilitate such product development.
Neurorehabilitation Devices Market Segmentation:
By Product:
- Non-Invasive Stimulators
- Wearable Devices
- Neurorobotics
- Brain-computer Interface
By Application:
- Traumatic Brain Injury
- Stroke
- Spinal Cord Injury
- Cerebral Palsy
- Parkinson’s Disease
- Other Applications
By Region:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of The World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Neurorehabilitation Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
- Non-Invasive Stimulators
- Wearable Devices
- Neurorobotics
- Brain-computer Interface
- Neurorehabilitation Devices Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
- Traumatic Brain Injury
- Stroke
- Spinal Cord Injury
- Cerebral Palsy
- Parkinson’s Disease
- Others
- Neurorehabilitation Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Neurorehabilitation Devices Market, By Country
- North America Neurorehabilitation Devices Market, By Product
- North America Neurorehabilitation Devices Market, By Application
- U.S. Neurorehabilitation Devices Market, By Product
- U.S. Neurorehabilitation Devices Market, By Application
- Canada Neurorehabilitation Devices Market, By Product
- Canada Neurorehabilitation Devices Market, By Application
- Mexico Neurorehabilitation Devices Market, By Product
- Mexico Neurorehabilitation Devices Market, By Application
-
- Europe
- Europe Neurorehabilitation Devices Market, By Country
- Europe Neurorehabilitation Devices Market, By Product
- Europe Neurorehabilitation Devices Market, By Application
- Germany Neurorehabilitation Devices Market, By Product
- Germany Neurorehabilitation Devices Market, By Application
- France Neurorehabilitation Devices Market, By Product
- France Neurorehabilitation Devices Market, By Application
- UK Neurorehabilitation Devices Market, By Product
- UK Neurorehabilitation Devices Market, By Application
- Italy Neurorehabilitation Devices Market, By Product
- Italy Neurorehabilitation Devices Market, By Application
- Spain Neurorehabilitation Devices Market, By Product
- Spain Neurorehabilitation Devices Market, By Application
- Rest of Europe Neurorehabilitation Devices Market, By Product
- Rest of Europe Neurorehabilitation Devices Market, By Application
-
- Asia-Pacific
- Asia-Pacific Neurorehabilitation Devices Market, By Country
- Asia-Pacific Neurorehabilitation Devices Market, By Product
- Asia-Pacific Neurorehabilitation Devices Market, By Application
- Japan Neurorehabilitation Devices Market, By Product
- Japan Neurorehabilitation Devices Market, By Application
- Australia Neurorehabilitation Devices Market, By Product
- Australia Neurorehabilitation Devices Market, By Application
- India Neurorehabilitation Devices Market, By Product
- India Neurorehabilitation Devices Market, By Application
- South Korea Neurorehabilitation Devices Market, By Product
- South Korea Neurorehabilitation Devices Market, By Application
- Rest of Asia-Pacific Neurorehabilitation Devices Market, By Product
- Rest of Asia-Pacific Neurorehabilitation Devices Market, By Application
- Asia-Pacific
-
- Rest of the World
- Rest of the World Neurorehabilitation Devices Market, By Country
- Rest of the World Neurorehabilitation Devices Market, By Product
- Rest of the World Neurorehabilitation Devices Market, By Application
- Brazil Neurorehabilitation Devices Market, By Product
- Brazil Neurorehabilitation Devices Market, By Application
- South Africa Neurorehabilitation Devices Market, By Product
- South Africa Neurorehabilitation Devices Market, By Application
- Saudi Arabia Neurorehabilitation Devices Market, By Product
- Saudi Arabia Neurorehabilitation Devices Market, By Application
- Turkey Neurorehabilitation Devices Market, By Product
- Turkey Neurorehabilitation Devices Market, By Application
- United Arab Emirates Neurorehabilitation Devices Market, By Product
- United Arab Emirates Neurorehabilitation Devices Market, By Application
- Others Neurorehabilitation Devices Market, By Product
- Others Neurorehabilitation Devices Market, By Application
- Rest of the World
Table of Contents
1.Introduction
1.1.Report Description
1.2.Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2.Executive Summary
2.1.Key Highlights
3.Market Overview
3.1.Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2.Market Share Analysis
3.3.Market Dynamics
3.3.1. Drivers
3.3.1.1.Increasing Incidence of Neurological Disorders Worldwide
3.3.1.2.Technological Advancements in Neuroscience and Robotics
3.3.1.3.Increasing Prevalence of Geriatric Population Around the World
3.3.2. Restraints
3.3.2.1.High Cost of Neurorehabilitation Devices
3.3.2.2.Dearth of Skilled Professional to Operate Sophisticated Neurorehabilitation Devices
3.3.3. Opportunities
3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities
4.Neurorehabilitation Devices market, By Product
4.1.Introduction
4.2.The Neurorehabilitation Devices market Assessment and Forecast, By Product, 2017-2027
4.3.Non-Invasive Stimulators
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.Wearable Devices
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5.Neurorobotics
4.5.1.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.6.Brain-computer Interface
4.6.1.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.Neurorehabilitation Devices Market, By Application
5.1.Introduction
5.2.Neurorehabilitation Devices market Assessment and Forecast, By Application, 2017-2027
5.3.Traumatic Brain Injury
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4.Stroke
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5.Spinal Cord Injury
5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.6.Cerebral Palsy
5.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.7.Parkinson’s Disease
5.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.8.Other Applications
5.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.Neurorehabilitation Devices Market, By Region
6.1.Introduction
6.2.Neurorehabilitation DevicesMarket Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.Neurorehabilitation DevicesMarket Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.North America
6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.3.1.U.S.
6.4.3.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.1.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.3.2.Canada
6.4.3.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.2.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.3.3.Mexico
6.4.3.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.3.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.Europe
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.1.Germany
6.5.3.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.1.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.2.France
6.5.3.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.2.2.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.3.UK
6.5.3.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.3.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.4.Italy
6.5.3.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.5.Spain
6.5.3.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.6.Russia
6.5.3.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.7.Rest of Europe
6.5.3.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.7.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.Asia-Pacific
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.1.Japan
6.6.3.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.1.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.2.China
6.6.3.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.2.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.3.Australia
6.6.3.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.3.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.4.India
6.6.3.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.5.South Korea
6.6.3.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.6.Taiwan
6.6.3.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.7.Rest of Asia-Pacific
6.6.3.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.7.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.Rest of the World
6.7.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.7.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.1.Brazil
6.7.3.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.1.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.2.Turkey
6.7.3.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.2.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.3.Saudi Arabia
6.7.3.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.3.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.4.South Africa
6.7.3.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.5.United Arab Emirates
6.7.3.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.7.3.6.Others
6.7.3.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.7.3.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.Company Profiles
7.1.Bioness Inc.
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.2.Hocoma AG
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.3.St. Jude Medical, Inc. (Acquired by Abbott Laboratories Inc.)
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4.Tyromotion GmbH
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.5.Medtronic plc
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments
7.6.AlterG, Inc.
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.7.Ekso Bionics Holdings, Inc.
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Key Financials
7.7.4. Strategic Developments
7.8.Biometrics Ltd
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.9. Bionik Laboratories Corp
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Key Financials
7.9.4. Strategic Developments
7.10.Kinova Robotics
7.10.1.Business Overview
7.10.2.Product Portfolio
7.10.3.Strategic Developments
7.11.Saebo, Inc.
7.11.1.Business Overview
7.11.2.Product Portfolio
7.11.3.Strategic Developments
7.12.Kinestica
7.12.1.Business Overview
7.12.2.Product Portfolio
7.12.3.Strategic Developments
List of Tables
Table 1.Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 2.Non-Invasive Stimulators Market, By Region ($Million), 2017-2025 ($Million)
Table 3.Wearable Devices Market, By Region ($Million), 2017-2025 ($Million)
Table 4.Neurorobotics Market, By Region ($Million), 2017-2025 ($Million)
Table 5.Brain-computer Interface Market, By Region ($Million), 2017-2025 ($Million)
Table 6.Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 7.Traumatic Brain Injury Market, By Region, 2017-2025 ($Million)
Table 8.Stroke Market, By Region, 2017-2025 ($Million)
Table9.Spinal Cord Injury Market, By Region, 2017-2025, ($Million)
Table 10.Cerebral Palsy Market, By Region, 2017-2025, ($Million)
Table 11.Parkinson’s Disease Market, By Region, 2017-2025, ($Million)
Table 12.Other Applications Market, By Region, 2017-2025, ($Million)
Table 13.Neurorehabilitation Devices Market, By Region, 2017-2025 ($Million)
Table 14.North America Neurorehabilitation Devices Market, By Country, 2017-2025 ($Million)
Table 15.North America Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 16.North America Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 17.U.S. Neurorehabilitation Devices Market, by Product, 2017-2025 ($Million)
Table 18.U.S. Neurorehabilitation Devices Market, by Application, 2017-2025 ($Million)
Table 19.Canada Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 20.Canada Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 21.Mexico Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 22.Mexico Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 23.Europe Neurorehabilitation Devices Market, By Country, 2017-2025 ($Million)
Table 24.Europe Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 25.Europe Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 26.Germany Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 27.Germany Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 28.France Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 29.France Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 30.UK Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 31.UK Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 32.Italy Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 33.Italy Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 34.Spain Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 35.Spain Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 36.Russia Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 37.Russia Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 38.Rest of Europe Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 39.Rest of Europe Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 40.Asia-Pacific Neurorehabilitation Devices Market, By Country, 2017-2025 ($Million)
Table 41.Asia-Pacific Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 42.Asia-Pacific Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 43.Japan Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 44.Japan Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 45.China Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 46.China Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 47.Australia Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 48.Australia Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 49.India Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 50.India Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 51.South Korea Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 52.South Korea Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 53.Taiwan Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 54.Taiwan Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 55.Rest of Asia-Pacific Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 56.Rest of Asia-Pacific Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 57.Rest of the World Neurorehabilitation Devices Market, By Country, 2017-2025 ($Million)
Table 58.Rest of the World Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 59.Rest of the World Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 60.Brazil Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 61.Brazil Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 62.Turkey Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 63.Turkey Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 64.Saudi Arabia Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 65.Saudi Arabia Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 66.South Africa Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 67.South Africa Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 68.United Arab Emirates Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 69.United Arab Emirates Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 70.Others Neurorehabilitation Devices Market, By Product, 2017-2025 ($Million)
Table 71.Others Neurorehabilitation Devices Market, By Application, 2017-2025 ($Million)
Table 72.Bioness Inc.: Key Strategic Developments, 2017-2017
Table 73.Hocoma AG: Key Strategic Developments, 2017-2017
Table 74.St. Jude Medical, Inc.: Key Strategic Developments, 2017-2017
Table 75.Tyromotion GmbH: Key Strategic Developments, 2017-2017
Table 76.Medtronic plc: Key Strategic Developments, 2017-2017
Table 77.AlterG, Inc.: Key Strategic Developments, 2017-2017
Table 78.Ekso Bionics Holdings, Inc.: Key Strategic Developments, 2017-2017
Table 79.Biometrics Ltd: Key Strategic Developments, 2017-2017
Table 80.Bionik Laboratories Corp: Key Strategic Developments, 2017-2017
Table 81.Kinova Robotics: Key Strategic Developments, 2017-2017
Table 82.Saebo, Inc.: Key Strategic Developments, 2017-2017
Table 83.Kinestica: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Neurorehabilitation Devices Market Share, By Product, 2017 & 2025 ($Million)
Figure 2.Neurorehabilitation Devices Market, By Application, 2017 & 2025, ($Million)
Figure 3.Neurorehabilitation Devices Market, By Region, 2017 & 2025, ($Million)
Figure 4.Abbott Laboratories Inc.: Net Revenues, 2017-2017 ($Million)
Figure 5.Abbott Laboratories Inc.: Net Revenue Share, By Segment, 2017
Figure 6.Abbott Laboratories Inc.: Net Revenue Share, By Geography, 2017
Figure 7.Medtronic plc: Net Revenues, 2017-2017 ($Million)
Figure 8.Medtronic plc: Net Revenue Share, By Segment, 2017
Figure 9.Medtronic plc: Net Revenue Share, By Geography, 2017
Figure 10.Ekso Bionics Holdings, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 11.Ekso Bionics Holdings, Inc.: Net Revenue Share, By Segment, 2017
Figure 12.Ekso Bionics Holdings, Inc.: Net Revenue Share, By Geography, 2017
Figure 13.Bionik Laboratories Corp: Net Revenues, 2017-2017 ($Million)
Figure 14.Bionik Laboratories Corp: Net Revenue Share, By Segment, 2017
Figure 15.Bionik Laboratories Corp: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|